Brain Imaging of Patients Suffering from Cancer

Author: Tashiro Manabu//Kamada Maki//Itoh Masatoshi//Kumano Hiroaki////
Div. of Nuclear Medicine, Cyclotron Radioisotope Center, Tohoku Univ. (Sendai, Japan)//Laboratory of Neuroinfomation Science, Tohoku-Gakuin Univ. (Sendai, Japan)//Dept. of Human Behavioral Science, Tohoku Univ. School of Medicine (Sendai, Japan)//Dept. of Nuclear Medicine and Radiology, Institute of Development, Aging and Cancer//Dept. of Ophthalmology, Tohoku Univ. School of Medicine//Dept. of Geriatric Medicine, Tohoku Univ. School of Medicine
Conference/Journal: J Intl Soc Life Info Science
Date published: 1997
Other: Volume ID: 15 , Issue ID: 2 , Pages: 408-409 , Word Count: 61

Brain data obtained from 19 lung cancer patients by 18F-fluorodeoxyglucose positron emission tomography (18-F-FDG-PET) were compared with those of ten inpatients with a benign disease. Reduction of regional brain metabolism was found in cancer patients mainly in the bilateral orbitofrontal cortices and putamen. Activated regions were the posterior parietal and visual cortices. The hypothalamus did not show changes in the glucose metabolism.